目的:探讨血管内皮细胞生长因子(VEGF)基因多态与血浆VEGF浓度以及脑卒中患病风险的关系。方法:采用PCR和限制性酶切片段长度多态性(RFLP)的方法,对1849例脑卒中患者和1798例对照者检测了VEGF基因启动子多态-460T/C、-116G/A和+405G/C的频率分布。Logistic回归模型校正传统危险因素后分析多态与脑卒中的独立相关性。ELISA法检测血浆VGEF浓度。结果:脑卒中组血浆VEGF水平显著高于对照组[分别为(291±61.9)ng/L、(225±56.3)ng/L;P〈0.01];VEGF基因多态-460T/C,-116G/A和+405G/c与血浆VEGF浓度不相关(相关系数分别是:r=-0.119,P〉0.05;r=0.173,P〉0.05;r=0.144,P〉0.05)。未发现VEGF基因多态与脑卒中的患病风险具有相关性。结论:脑卒中组血浆VEGF水平升高支持VEGF在脑卒中发病过程中的作用,但VEGF基因5'-调控区多态与脑卒中的易感性不相关。
Objective:To assess the gene polymorphisms and concentration of vascular endothelial growth factor (VEGF) and the risk for stoke. Method:Total 1 849 patients with stroke (43.9 % cerebral atherothrombosis, 28. 7 % lacunar infarction, and 27.4 % intracerebral hemorrhage) and 1 798 controls were recruited from 7 centers. Three polymorphisms of -460T/C, -116G/A, and +405G/C in the VEGF gene were genotyped by PCR-RFLP assays. Multivariate logistic regression model was used to exclude the influence of conventional vascular risk factors on the risk of stroke. VEGF plasma level was measured by ELISA. Result:Plasma VEGF levels were significantly higher in cases than in controls [-291±61.9] versus [-225±56.3]ng/L, P〈0.01). However, no significant correlation was found between the tested VEGF polymorphisms and VEGF levels (- 460T/C: r=-0.119,P=0.37;-116G/A; r=0.173,P=0.19;+405G/C: r=0.144,P=0.27; respectively). All VEGF markers were not associated with stroke after adjustment for established vascular risk factors. Concluion:These data suggested that elevated levels of plasma VEGF might play a role in the development of stroke, while polymorphisms in the 5'-regulatory region of VEGF gene did not contribute to stroke.